Surgalign Holdings Schedules Fourth Quarter and Full Year 2020 Earnings Call for March 11, 2021
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced plans to release its financial results for Q4 and the full year 2020 on March 11, 2021, after market close. A conference call is scheduled for 4:30 p.m. ET that day, accessible via U.S. and international dialing options. The company focuses on spine surgery advancements and improving patient outcomes through digital technology. It operates in over 50 countries, driven by a commitment to clinical innovation. Interested parties can access the conference call via the investor section of Surgalign's website.
- Plans to release Q4 and full year 2020 financial results on March 11, 2021.
- Conducting a conference call to discuss results, enhancing investor communication.
- Focus on advancing spine surgery and patient outcomes, indicating strong market positioning.
- None.
DEERFIELD, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced it plans to release financial results from the fourth quarter and full year 2020 after the close of trading on Thursday, March 11, 2021.
Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (877) 383-7419 (U.S.) or (760) 666-3754 (International), using conference ID 1277107. The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for one month following the call.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Jonathon Singer
Investor and Media Contact
jsinger@surgalign.com
+1 877-343-6832
FAQ
When will Surgalign release its Q4 2020 financial results?
What time is the Surgalign conference call scheduled for?
How can I access Surgalign's conference call?
What is Surgalign focused on?
